Alain Cohen-Solal
Alain Cohen-Solal is an expert in Cardiology at Hôpital Lariboisière (France). As of October 2026, ScienceLeadR ranks Alain Cohen-Solal in the top 1% of experts worldwide for Heart Failure, and in the top 1% of experts in France for Iron Deficiencies. Alain Cohen-Solal has authored 566 publications, the most recent in 2025, and is an investigator in 14 clinical trials, 1 of them ongoing. SLR score: 1,842 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Nephrology - Internal Medicine
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1987 - 2025
Number : 566
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Predicting cardiovascular events in allogeneic hematopoietic stem cell transplant recipients. PMID 41026898 — cells, hypertension, microscopy, electron, scanning transmission, heart failure, cardiovascular diseases, stem cells, cardiotoxicity, transplants, cell transplantation, history, hematopoietic stem cells, allografts, transplantation, demography | Eur J Prev Cardiol | 2025 | 1 |
| Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology. PMID 40070307 — quality of life, heart failure, heart, cardiovascular diseases, cardiology, signs and symptoms | Eur J Prev Cardiol | 2025 | 13 |
| Qsox1 contributes to vascular remodelling in response to hypertension. PMID 40753967 — cells, hypertension, heart failure, lymphatic system, heart, cardiovascular system, phenotype, hypertrophy, angiotensins, blood vessels | J Vasc Res | 2025 | 1 |
| Predicting 1-year heart failure hospitalization and mortality post-discharge from the intensive cardiac care unit. PMID 40396440 — mortality, hospitalization, heart failure, heart | ESC Heart Fail | 2025 | 0 |
| In-hospital and 1 year incremental prognostic value of drug abuse detection in acute heart failure. PMID 40396434 — heart failure, pharmaceutical preparations, substance abuse detection, heart | ESC Heart Fail | 2025 | 0 |
Clinical Studies 14
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Addiction in Intensive Cardiac Care Units NCT05063097 — dronabinol, antidepressive agents, research design, buprenorphine, heart diseases, n-methyl-3,4-methylenedioxyamphetamine, heroin, hospitalization, cocaine, methadone, pharmaceutical preparations, benzodiazepines, heart, substance-related disorders, psychotropic drugs, prevalence, tobacco use, intensive care units, barbiturates, amphetamines, smoking, cannabinoids, antidepressive agents, tricyclic, illicit drugs | N/A | Active not recruiting | 2021 |
LeadR Networks
Main global connection map